Category: Disclosures

[Disclosure] Hanmi Semiconductor (042700) – Decision on Termination of Trust Contract for Treasury Stock Acquisition / 2024-10-23

October 23, 2024August 1, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary The company terminated its KRW 50.0B treasury stock acquisition trust contract with Samsung Securities due to contract expiration. A total of 333,800 treasury shares were acquired under this trust and will be returned to the company’s corporate account in cash and physical shares. 📊 [Key Disclosure…

Semiconductors, Disclosures

[Disclosure] Samsung Biologics (207940) – (Correction) Forecast on Operating Results Based on Consolidated Financial Statements (Fair Disclosure) / 2024-10-23

October 23, 2024August 7, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics has issued a correction disclosure raising its FY2024 consolidated revenue forecast from KRW 4.1564T to KRW 4.3411T, driven by successful ramp-up of Plant 4 utilization and favorable foreign exchange conditions. 📊 [Key Disclosure Details & Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌…

Disclosures, Bio & Healthcare

[Disclosure] Samsung Biologics (207940) – Provisional Operating Results Based on Consolidated Financial Statements (Fair Disclosure) / 2024-10-23

October 23, 2024August 7, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics has disclosed its provisional Q3 2024 consolidated revenue of KRW 1.1871T (+14.81% YoY) and operating profit of KRW 338.6B (+6.29% YoY). Cumulative revenue for the first three quarters reached KRW 3.2909T, with cumulative operating profit at KRW 994.4B. 📊 [Key Disclosure Details & Financial…

Disclosures, Bio & Healthcare

[Disclosure] Hanwha Systems (272210) – Change in CEO (Executive Officer) Announcement / 2024-10-22

October 22, 2024August 11, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Systems has appointed Jae-il Son as its new CEO through a Board of Directors resolution, replacing former CEO Sung-chul Eo. 📊 [Key Disclosure Details & Financial Metrics] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Governance Changes and Reflection in Official Corporate Filings This disclosure pertains…

Disclosures, Defense

[Disclosure] Samsung Biologics (207940) – Single Sales and Supply Contract / 2024-10-22

October 22, 2024August 7, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics has disclosed the signing of a pharmaceutical contract manufacturing agreement with an Asia-based pharmaceutical company valued at approx. KRW 1.7028T (USD 1,242,560,000), representing 46.09% of its FY2023 consolidated revenue. 📊 [Key Disclosure Details & Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Monitoring…

Disclosures, Bio & Healthcare

[Disclosure] Jusung Engineering (036930) – Notice on Market Actions for Stock Futures and Options (Re-notice on Stock Futures Market Actions Due to Corporate Spin-off) / 2024-10-22

October 22, 2024August 3, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Following the shareholder approval of Jusung Engineering’s corporate spin-off, the final trading day for stock futures contract months from Nov 2024 to Sep 2025 has been adjusted to October 29, 2024. 📊 [Key Disclosure Contents & Major Figures Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌…

Semiconductors, Disclosures

[Disclosure] Celltrion (068270) – Single Sales / Supply Contract / 2024-10-22

October 22, 2024August 6, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion announced that it has signed a contract manufacturing and development (CDMO) supply agreement worth approximately KRW 100.0B with TEVA Pharmaceuticals International GmbH for the active pharmaceutical ingredient (API) of the migraine treatment AJOVY®. 📊 [Key Disclosure Details & Financial Highlights] 📝 Editor’s Comment (Key Follow-up…

Disclosures, Bio & Healthcare

[Disclosure] Hyundai Motor (005380) – (Correction) Decision on Disposal of Shares and Investment Certificates of Other Corporations / 2024-10-22

October 22, 2024August 12, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hyundai Motor issued a corrected disclosure confirming the final disposal amount for the sale of existing shares in its Indian subsidiary (HYUNDAI MOTOR INDIA LIMITED) at KRW 4.39T, following the completion of the disposal with the final offer price set at 1,960 INR per share. 📊…

Disclosures, Automotive

[Disclosure] Hanwha Systems (272210) – Results of Extraordinary General Meeting of Shareholders / 2024-10-22

October 22, 2024August 11, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Systems held an Extraordinary General Meeting of Shareholders and approved the appointment of Jae-il Son as Inside Director as originally proposed. 📊 [Key Disclosure Details & Financial Metrics] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Changes in Board Composition and Governance Reflections This disclosure reports…

Disclosures, Defense

[Disclosure] Hanmi Semiconductor (042700) – Investor Relations (IR) Presentation / 2024-10-21

October 21, 2024August 1, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary The company will hold a conference call IR session sponsored by Nomura Securities for major overseas institutional investors across the Americas, Europe, and Asia to present its Q3 2024 business performance, TC Bonder demand diversification, and dedicated HBM chip market growth. 📊 [Key Disclosure Contents &…

Semiconductors, Disclosures